Past Events There are no past events available at this time. Presentations September 2023 Corporate Presentation 5.1 MB AASLD 2023: Prime Editing precisely corrects prevalent mutations observed in Glycogen Storage Disease Type 1b (GSD1b) patients 1.3 MB ESGCT 2023: Prime editing precisely corrects prevalent pathogenic mutations causing Glycogen Storage Disease Type 1b (GSD1b) 2.4 MB OTS 2023: Recent Advances in Non-Viral Delivery of Prime Editors Toward the Treatment of Patients with Glycogen Storage Disease Type 1b 2.7 MB RD2023: Prime Editors efficiently and precisely correct pathological mutations causing rhodopsin associated autosomal dominant retinitis pigmentosa (adRP) 2.5 MB AIChE CRISPR Technologies Presentation: Developing Prime Editors to Treat Repeat Expansion Diseases 10.3 MB Stem Cell Clonality and Genome Stability Retreat at ESGCT Presentation: Prime Editing in Hematopoietic Diseases and Beyond: Efficacy and Safety 2.6 MB
AASLD 2023: Prime Editing precisely corrects prevalent mutations observed in Glycogen Storage Disease Type 1b (GSD1b) patients 1.3 MB
AASLD 2023: Prime Editing precisely corrects prevalent mutations observed in Glycogen Storage Disease Type 1b (GSD1b) patients 1.3 MB
ESGCT 2023: Prime editing precisely corrects prevalent pathogenic mutations causing Glycogen Storage Disease Type 1b (GSD1b) 2.4 MB
ESGCT 2023: Prime editing precisely corrects prevalent pathogenic mutations causing Glycogen Storage Disease Type 1b (GSD1b) 2.4 MB
OTS 2023: Recent Advances in Non-Viral Delivery of Prime Editors Toward the Treatment of Patients with Glycogen Storage Disease Type 1b 2.7 MB
OTS 2023: Recent Advances in Non-Viral Delivery of Prime Editors Toward the Treatment of Patients with Glycogen Storage Disease Type 1b 2.7 MB
RD2023: Prime Editors efficiently and precisely correct pathological mutations causing rhodopsin associated autosomal dominant retinitis pigmentosa (adRP) 2.5 MB
RD2023: Prime Editors efficiently and precisely correct pathological mutations causing rhodopsin associated autosomal dominant retinitis pigmentosa (adRP) 2.5 MB
AIChE CRISPR Technologies Presentation: Developing Prime Editors to Treat Repeat Expansion Diseases 10.3 MB
AIChE CRISPR Technologies Presentation: Developing Prime Editors to Treat Repeat Expansion Diseases 10.3 MB
Stem Cell Clonality and Genome Stability Retreat at ESGCT Presentation: Prime Editing in Hematopoietic Diseases and Beyond: Efficacy and Safety 2.6 MB
Stem Cell Clonality and Genome Stability Retreat at ESGCT Presentation: Prime Editing in Hematopoietic Diseases and Beyond: Efficacy and Safety 2.6 MB